QPTFF (Quest PharmaTech) EPS without NRI: $0.01 (TTM As of Jan. 2026)


What is Quest PharmaTech EPS without NRI?

Quest PharmaTech QPTFF EPS without NRI is $0.01 as of Jan. 2026. Among 1,168 Biotechnology companies, Quest PharmaTech ranks worse than 85616.35% on this metric.

Quest PharmaTech's earnings per share without non-recurring items for the three months ended in Jan. 2026 was $0.00. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jan. 2026 was $0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Quest PharmaTech's EPS without NRI or its related term are showing as below:

During the past 13 years, Quest PharmaTech's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 71.50% per year. The lowest was -128.50% per year. And the median was 0.00% per year.

QPTFF's 3-Year EPS without NRI Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 16.4
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Quest PharmaTech's EPS (Diluted) for the three months ended in Jan. 2026 was $0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2026 was $0.02.

Quest PharmaTech's EPS (Basic) for the three months ended in Jan. 2026 was $0.02. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2026 was $0.02.


Quest PharmaTech  (OTCPK:QPTFF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Quest PharmaTech EPS without NRI Related Terms


Quest PharmaTech EPS without NRI Historical Data

* Premium members only.

The historical data trend for Quest PharmaTech's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest PharmaTech EPS without NRI Chart

Quest PharmaTech Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.27 -0.01 -0.01 -0.01 0.01

Quest PharmaTech Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 0.00 -0.00 0.01 0.00

QPTFF vs VRTX, REGN, ALNY: EPS without NRI Comparison

For the Biotechnology subindustry, Quest PharmaTech's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest PharmaTech PE Ratio without NRI vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quest PharmaTech's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Quest PharmaTech's PE Ratio without NRI falls into.



Quest PharmaTech EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $0.01 mean?
Quest PharmaTech (QPTFF) has a EPS without NRI of $0.01 as of Jan. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Quest PharmaTech and its competitors. According to the industry distribution chart, Quest PharmaTech ranks #999999 out of 1168 companies in the Biotechnology industry.
Is Quest PharmaTech's EPS without NRI too high?
Quest PharmaTech's current EPS without NRI is $0.01. The Biotechnology industry median EPS without NRI is 16.40. Quest PharmaTech's value of $0.01 is 99.9% below this industry median. Based on the distribution chart, Quest PharmaTech ranks #999999 out of 1168 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Quest PharmaTech's EPS without NRI compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Quest PharmaTech ranks #999999 out of 1168 companies for EPS without NRI. This places Quest PharmaTech in the lower half of its industry. The industry median EPS without NRI is 16.40. Quest PharmaTech's value of $0.01 is 99.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Biotechnology company?
The median EPS without NRI among Biotechnology companies is 16.40, based on 1,168 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Quest PharmaTech's current EPS without NRI of $0.01 is 99.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Quest PharmaTech and its competitors. For the Biotechnology industry, the median EPS without NRI is 16.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quest PharmaTech's current EPS without NRI is $0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest PharmaTech stock overvalued right now?
Quest PharmaTech (QPTFF) has a current EPS without NRI of $0.01. The current EPS without NRI is $0.01 and 99.9% below the Biotechnology industry median of 16.40. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Quest PharmaTech (QPTFF), the current EPS without NRI is $0.01 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quest PharmaTech Business Description

Other Exchanges QPT:Canada
Address 4342- 97 Street NW, Edmonton, AB, CAN, T6E 5R9
Quest PharmaTech Inc is developing targeted cancer therapy with its product (MAb AR9.6), under development for a novel target (truncated O-glycans on MUC16) discovered at the University of Nebraska Medical Center.